| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms.
|
J Clin Invest
|
2003
|
3.02
|
|
2
|
Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo.
|
Nat Med
|
2004
|
2.51
|
|
3
|
Apurinic/apyrimidinic endonuclease 1 regulates endothelial NO production and vascular tone.
|
Circ Res
|
2004
|
1.81
|
|
4
|
STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells.
|
Blood
|
2004
|
1.58
|
|
5
|
Mechanism of impaired regeneration of fatty liver in mouse partial hepatectomy model.
|
J Gastroenterol Hepatol
|
2007
|
1.46
|
|
6
|
Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice.
|
J Hepatol
|
2005
|
1.31
|
|
7
|
The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation.
|
Hepatology
|
2009
|
1.26
|
|
8
|
Trps1 regulates proliferation and apoptosis of chondrocytes through Stat3 signaling.
|
Dev Biol
|
2007
|
1.16
|
|
9
|
Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma.
|
Pancreas
|
2011
|
1.06
|
|
10
|
BlotGlycoABCTM, an integrated glycoblotting technique for rapid and large scale clinical glycomics.
|
Mol Cell Proteomics
|
2007
|
1.03
|
|
11
|
Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases.
|
J Hepatobiliary Pancreat Sci
|
2011
|
1.03
|
|
12
|
Stat3 confers resistance against hypoxia/reoxygenation-induced oxidative injury in hepatocytes through upregulation of Mn-SOD.
|
J Hepatol
|
2004
|
1.03
|
|
13
|
Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients.
|
Oncol Rep
|
2010
|
1.03
|
|
14
|
Vascular endothelial growth factor regulation of Weibel-Palade-body exocytosis.
|
Blood
|
2004
|
1.01
|
|
15
|
Signal transducer and activator of transcription 3alpha and specificity protein 1 interact to upregulate intercellular adhesion molecule-1 in ischemic-reperfused myocardium and vascular endothelium.
|
Arterioscler Thromb Vasc Biol
|
2005
|
0.99
|
|
16
|
Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma.
|
Oncol Rep
|
2010
|
0.99
|
|
17
|
Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells.
|
Immunol Cell Biol
|
2005
|
0.97
|
|
18
|
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
|
J Crohns Colitis
|
2011
|
0.97
|
|
19
|
p66(Shc) has a pivotal function in impaired liver regeneration in aged mice by a redox-dependent mechanism.
|
Lab Invest
|
2010
|
0.95
|
|
20
|
Hypoxia/re-oxygenation-induced, redox-dependent activation of STAT1 (signal transducer and activator of transcription 1) confers resistance to apoptotic cell death via hsp70 induction.
|
Biochem J
|
2004
|
0.94
|
|
21
|
AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
|
Ann Surg
|
2006
|
0.93
|
|
22
|
In vivo far-red luminescence imaging of a biomarker based on BRET from Cypridina bioluminescence to an organic dye.
|
Proc Natl Acad Sci U S A
|
2009
|
0.90
|
|
23
|
Tie-ing the antiinflammatory effect of angiopoietin-1 to inhibition of NF-kappaB.
|
Circ Res
|
2003
|
0.89
|
|
24
|
Donor pretreatment with DHMEQ improves islet transplantation.
|
J Surg Res
|
2010
|
0.88
|
|
25
|
Contribution of toll-like receptor 2 to the innate response against Staphylococcus aureus infection in mice.
|
PLoS One
|
2013
|
0.88
|
|
26
|
Preventing hypoxia/reoxygenation damage to hepatocytes by p66(shc) ablation: up-regulation of anti-oxidant and anti-apoptotic proteins.
|
J Hepatol
|
2007
|
0.88
|
|
27
|
The novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/reperfusion in rats.
|
J Surg Res
|
2008
|
0.87
|
|
28
|
Autonomic regulation of liver regeneration after partial hepatectomy in mice.
|
J Surg Res
|
2008
|
0.86
|
|
29
|
Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
|
Transplantation
|
2006
|
0.85
|
|
30
|
Hepatic ischemia induced immediate oxidative stress after reperfusion and determined the severity of the reperfusion-induced damage.
|
Antioxid Redox Signal
|
2009
|
0.84
|
|
31
|
Platelets Strongly Induce Hepatocyte Proliferation with IGF-1 and HGF In Vitro.
|
J Surg Res
|
2007
|
0.84
|
|
32
|
Obstructive jaundice increases sensitivity to lipopolysaccharide via TLR4 upregulation: possible involvement in gut-derived hepatocyte growth factor-protection of hepatocytes.
|
J Gastroenterol Hepatol
|
2005
|
0.84
|
|
33
|
Protective effects of nafamostat mesilate on liver injury induced by lipopolysaccharide in rats: possible involvement of CD14 and TLR-4 downregulation on Kupffer cells.
|
Dig Dis Sci
|
2006
|
0.84
|
|
34
|
Inhibition of macrophage activation and suppression of graft rejection by DTCM-glutarimide, a novel piperidine derived from the antibiotic 9-methylstreptimidone.
|
Inflamm Res
|
2011
|
0.84
|
|
35
|
Inhibition of nuclear factor-kappaB suppresses peritoneal dissemination of gastric cancer by blocking cancer cell adhesion.
|
Cancer Sci
|
2011
|
0.83
|
|
36
|
Hepatic reticuloendothelial system dysfunction after ischemia-reperfusion: role of P-selectin-mediated neutrophil accumulation.
|
Liver Transpl
|
2003
|
0.83
|
|
37
|
Transduction of exogenous constitutively activated Stat3 into dispersed islets induces proliferation of rat pancreatic beta-cells.
|
Tissue Eng
|
2006
|
0.83
|
|
38
|
The role of STAT3 in liver regeneration.
|
Drugs Today (Barc)
|
2005
|
0.83
|
|
39
|
Taurine chloramine: a possible oxidant reservoir.
|
Adv Exp Med Biol
|
2009
|
0.83
|
|
40
|
Array comparative genomic hybridization analysis revealed four genomic prognostic biomarkers for primary gastric cancers.
|
Cancer Genet Cytogenet
|
2010
|
0.82
|
|
41
|
Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.
|
Invest Ophthalmol Vis Sci
|
2009
|
0.82
|
|
42
|
Ex vivo adenoviral gene transfer of constitutively activated STAT3 reduces post-transplant liver injury and promotes regeneration in a 20% rat partial liver transplant model.
|
Transpl Int
|
2006
|
0.82
|
|
43
|
Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-κB inhibitor, (-)-DHMEQ.
|
Oncol Res
|
2013
|
0.81
|
|
44
|
Involvement of prostaglandin receptors (EPR2-4) in in vivo immunosuppression of PGE2 in rat skin transplant model.
|
Int Immunopharmacol
|
2005
|
0.81
|
|
45
|
Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway.
|
Transplantation
|
2013
|
0.81
|
|
46
|
p62/SQSTM1 plays a protective role in oxidative injury of steatotic liver in a mouse hepatectomy model.
|
Antioxid Redox Signal
|
2014
|
0.80
|
|
47
|
α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma.
|
World J Gastroenterol
|
2012
|
0.80
|
|
48
|
Activation of c-Jun N-terminal kinase is essential for oxidative stress-induced Jurkat cell apoptosis by monochloramine.
|
Leuk Res
|
2008
|
0.79
|
|
49
|
Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance.
|
Transplantation
|
2013
|
0.79
|
|
50
|
Surgical stress and tumor behavior: impact of ischemia-reperfusion and hepatic resection on tumor progression.
|
Liver Transpl
|
2007
|
0.78
|
|
51
|
Small liver graft regenerates through immediate increase of HGF and IL-6--possible involvement of sinusoidal tensile/shear stress in small liver graft.
|
Hepatogastroenterology
|
2008
|
0.78
|
|
52
|
Signal transducer and activator of transcription 3 upregulates interleukin-8 expression at the level of transcription in human melanoma cells.
|
Exp Dermatol
|
2010
|
0.78
|
|
53
|
Rapid methods of detecting the target molecule in immunohistology using a bioluminescence probe.
|
Luminescence
|
2012
|
0.78
|
|
54
|
Topical application of dehydroxymethylepoxyquinomicin improves allergic inflammation via NF-kappaB inhibition.
|
J Allergy Clin Immunol
|
2010
|
0.77
|
|
55
|
Successful transplantation of rat hearts subjected to extended cold preservation with a novel preservation solution.
|
Transpl Int
|
2012
|
0.77
|
|
56
|
A simple and reliable method for determining plasma concentration of dehydroxymethylepoxyquinomicin by high performance liquid chromatography with mass spectrometry.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2008
|
0.77
|
|
57
|
Oxidative modification of IkappaB by monochloramine inhibits tumor necrosis factor alpha-induced NF-kappaB activation.
|
Biochim Biophys Acta
|
2005
|
0.77
|
|
58
|
The impact of portal infusion with donor-derived bone marrow cells and intracellular cytokine expression of graft-infiltrating lymphocytes on the graft survival in rat small bowel transplant model.
|
Transpl Immunol
|
2004
|
0.77
|
|
59
|
Sustained accurate recording of intracellular acidification in living tissues with a photo-controllable bioluminescent protein.
|
Proc Natl Acad Sci U S A
|
2013
|
0.77
|
|
60
|
Growth arrest and DNA damage-inducible 34 regulates liver regeneration in hepatic steatosis in mice.
|
Hepatology
|
2015
|
0.77
|
|
61
|
Dendritic cells conditioned with NK026680 prolong cardiac allograft survival in mice.
|
Transplantation
|
2012
|
0.76
|
|
62
|
Deficient response of IL-6 impaired liver regeneration after hepatectomy in patients with viral hepatitis.
|
Hepatogastroenterology
|
2008
|
0.76
|
|
63
|
Improved hepatic regeneration with reduced injury by redox factor-1 in a rat small-sized liver transplant model.
|
Am J Transplant
|
2004
|
0.76
|
|
64
|
Prolonged survival of donor-specific rat intestinal allograft by administration of bone-marrow-derived immature dendritic cells.
|
Transpl Immunol
|
2005
|
0.76
|
|
65
|
Mutual modulation between interleukin-10 and interleukin-6 induced by Rhodococcus aurantiacus infection in mice.
|
Microbes Infect
|
2008
|
0.76
|
|
66
|
NK026680 inhibits T-cell function in an IL-2-dependent manner and prolongs cardiac allograft survival in rats.
|
Transpl Immunol
|
2011
|
0.76
|
|
67
|
Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: I. HMGB1 suppression by DHMEQ prevents early islet graft damage.
|
Transplantation
|
2013
|
0.76
|
|
68
|
Pathophysiological characteristics of melanoma in-transit metastasis in a lymphedema mouse model.
|
J Invest Dermatol
|
2012
|
0.76
|
|
69
|
Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients.
|
J Allergy Clin Immunol
|
2012
|
0.75
|
|
70
|
Identification of de novo STAT3 target gene in liver regeneration.
|
Hepatol Res
|
2007
|
0.75
|
|
71
|
Monochloramine inhibits ultraviolet B-induced p53 activation and DNA repair response in human fibroblasts.
|
Biochim Biophys Acta
|
2005
|
0.75
|
|
72
|
In vivo bioluminescence imaging of bone marrow-derived cells in brain inflammation.
|
Biochem Biophys Res Commun
|
2009
|
0.75
|
|
73
|
Oxidative stress enhances granulocytic differentiation in HL 60 cells, an acute promyelocytic leukemia cell line.
|
Free Radic Res
|
2010
|
0.75
|
|
74
|
Immunomodulatory effect of nuclear factor-κB inhibition by dehydroxymethylepoxyquinomicin in combination with donor-specific blood transfusion.
|
Transplantation
|
2012
|
0.75
|
|
75
|
Artificial mimicking of physiological active transport by a membrane co-cultured with two different cells: hepatic origin HepG2 and renal origin PCTL-MDR.
|
Artif Organs
|
2002
|
0.75
|
|
76
|
A method for intravital monitoring of human cells using a far-red luminescent probe in graft-versus-host disease model mice.
|
J Invest Dermatol
|
2012
|
0.75
|
|
77
|
Significant correlation between surgical stress of hepatectomy and changes in the serum levels of HGF, IL-6 and soluble Fas in patients with viral hepatitis.
|
Hepatogastroenterology
|
2008
|
0.75
|
|
78
|
[Development of novel cell culture systems utilizing the advantages of collagen vitrigel membrane].
|
Yakugaku Zasshi
|
2010
|
0.75
|
|
79
|
The role of a protease inhibitor against hepatectomy.
|
Hepatogastroenterology
|
2006
|
0.75
|